Discover 471 paid clinical trials in Little Rock, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Location: Little Rock AR, St Louis MO, Dallas TX, Nashville TN,
Sponsor: Mezzion Pharma Co. Ltd
Sex: All
Age: 12 - 18
Code: NCT05918211
Phase3, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Little Rock AR, Memphis TN, Jackson MS, Tulsa OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase3, Recruiting
Active & Responsive
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
for
Acute Myeloid Leukemia
Location: Little Rock AR, Memphis TN, Cincinnati OH, Madison WI,
Sponsor: Norman J. Lacayo
Sex: All
Age: 0 - 21
Code: NCT05101551
Phase1, Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Little Rock AR, St Louis MO, Houston TX, Atlanta GA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase2, Recruiting
Active & Responsive
Safety of MOON101 for the Treatment of Peanut Allergy
for
Peanut Allergy
Location: Little Rock AR, Overland Park KS, Atlanta GA,
Sponsor: Moonlight Therapeutics, Inc.
Sex: All
Age: 4 - 55
Code: NCT07580898
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
for
Peanut Allergy
Location: Little Rock AR, Cincinnati OH, Chapel Hill NC,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 12 - 55
Code: NCT07015996
Phase2, Recruiting
Active & Responsive
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
Location: Little Rock AR, Dallas TX, Houston TX, Atlanta GA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4+
Code: NCT05589714
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Little Rock AR, Tyler TX, Dallas TX, St Louis MO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase3, Recruiting
Active & Responsive
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
for
Surgery-Complications, Anesthesia Complication,
Location: Little Rock AR, St Louis MO, Dallas TX, Houston TX,
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT05991453
Recruiting
Active & Responsive
Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
for
Neonatal Opioid Withdrawal Syndrome
Location: Little Rock AR, Birmingham AL, Indianapolis IN,
Sponsor: HELP for NOWS Consortium
Sex: All
Age: 0+
Code: NCT07278375
Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
for
Huntington Disease
Location: Little Rock AR, Memphis TN, Nashville TN, Fairway KS,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 21 - 70
Code: NCT07326709
Phase3, Recruiting
Active & Responsive
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for
AAA, AAA - Abdominal Aortic Aneurysm
Location: Little Rock AR, Fayetteville AR, Columbia MO,
Sponsor: Endologix
Sex: All
Age: 21+
Code: NCT05064540
Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Little Rock AR, Fayetteville AR, Springdale AR,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Active & Responsive
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Little Rock AR, Cape Girardeau MO, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase2, Phase3, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Little Rock AR, Cape Girardeau MO, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase2, Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Little Rock AR, St Louis MO, O'Fallon IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase2, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Little Rock AR, Cape Girardeau MO, Osage Beach MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase3, Recruiting
Active & Responsive
Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease
for
Degenerative Disc Disease
Location: Little Rock AR, Shreveport LA, Frisco TX,
Sponsor: CGBio Inc.
Sex: All
Age: 21 - 70+
Code: NCT07017634
Phase3, Recruiting
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
for
Plasma Cell Myeloma
Location: Little Rock AR, Fort Smith AR, Branson MO,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT05561387
Phase3, Recruiting
Active & Responsive
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)